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Abstract
Cryptococcus gattii infections in southern California have been reported in patients with HIV/AIDS. In this study, we
examined the molecular epidemiology, population structure, and virulence attributes of isolates collected from HIV/AIDS
patients in Los Angeles County, California. We show that these isolates consist almost exclusively of VGIII molecular type, in
contrast to the VGII molecular type isolates causing the North American Pacific Northwest outbreak. The global VGIII
population structure can be divided into two molecular groups, VGIIIa and VGIIIb. Isolates from the Californian patients are
virulent in murine and macrophage models of infection, with VGIIIa significantly more virulent than VGIIIb. Several VGIII
isolates are highly fertile and produce abundant sexual spores that may serve as infectious propagules. The a and a VGIII
MAT locus alleles are largely syntenic with limited rearrangements compared to the known VGI (a/a) and VGII (a) MAT loci,
but each has unique characteristics including a distinct deletion flanking the 59 VGIII MATa alleles and the a allele is more
heterogeneous than the a allele. Our studies indicate that C. gattii VGIII is endemic in southern California, with other isolates
originating from the neighboring regions of Mexico, and in rarer cases from Oregon and Washington state. Given that
.1,000,000 cases of cryptococcal infection and .620,000 attributable mortalities occur annually in the context of the global
AIDS pandemic, our findings suggest a significant burden of C. gattii may be unrecognized, with potential prognostic and
therapeutic implications. These results signify the need to classify pathogenic Cryptococcus cases and highlight possible
host differences among the C. gattii molecular types influencing infection of immunocompetent (VGI/VGII) vs.
immunocompromised (VGIII/VGIV) hosts.
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Introduction
The pathogenic Cryptococcus species complex is comprised of two
common fungal pathogens of humans and other animals: C.
neoformans and C. gattii [1]. The more prevalent C. neoformans is
ubiquitously distributed worldwide and a common cause of
meningitis in immunocompromised hosts [1,2,3]. C. gattii is more
geographically restricted to tropical and subtropical regions,
associated with eucalypts, Douglas fir, and other trees, and has a
greater predilection for infecting immunocompetent hosts [4,5].
However, the geographic distribution of this species has been
expanding, with an outbreak occurring in the Pacific Northwest
region of North America [4,5,6,7,8,9,10,11,12]. C. gattii can be
subdivided into two serotypes (B and C) [13] and four molecular
types (VGI, VGII, VGIII, VGIV) that appear to represent
genetically isolated cryptic species [14,15,16]. VGI and VGII
cause the majority of cases in otherwise healthy hosts. VGIII and
VGIV appear to more commonly infect immunocompromised
patients, including those with HIV/AIDS, similar to C. neoformans
[3,5,17,18,19].
Compared to C. neoformans, less is known about the epidemiol-
ogy and ecology of C. gattii, especially molecular types VGIII and
VGIV. VGIV is rare globally but has been reported to cause
infections in sub-Saharan Africa AIDS patients [18], while VGIII
has been isolated from a number of regions worldwide [14,16].
The limited epidemiological data may be due to a lack of
laboratory species distinction, particularly in Cryptococcus cases
among HIV/AIDS patients, although sporadic C. gattii infections
in HIV/AIDS patients have been reported from many global
regions [18,20,21,22,23,24,25,26,27,28,29,30].
There are limited accounts for HIV/AIDS or VGIII/VGIV
associated C. gattii in North America. However, C. gattii has been
reported in southern California among an HIV/AIDS patient
cohort and one AIDS patient in Mexico, and C. gattii VGIII/
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[21,22,31]. Additionally, there are three reported VGIII isolates
from the Pacific Northwest outbreak [6,7,10]. These reports
suggest that C. gattii may be endemic in western North America.
Here we compared isolates from HIV/AIDS patients in
southern California [22] with a global collection. Based on MLST
analyses, .93% (28/30) of the C. gattii isolate cohort are VGIII,
and genotypic diversity is much greater than in the Pacific
Northwest VGII outbreak. The genotypes cluster into two distinct
groups (VGIIIa, VGIIIb). These findings suggest that VGIII may
have been endemic in southern California for a longer period of
time compared to the more clonal VGII Pacific Northwest
population, or that VGIII is more actively recombining and/or
mutating. The high levels of diversity, together with results
suggesting recombination, support ongoing genetic exchange.
The VGIII lineage is highly fertile compared to other C. gattii
molecular types [32]. Isolates from our cohort include both mating
types (a and a), unlike the exclusively a mating type Pacific
Northwest outbreak [7,16]. This is noteworthy, as a-a mating can
promote recombination and yield infectious spores
[33,34,35,36,37,38]. Sexual recombination is critical in evolution
of eukaryotic microbial pathogens, including both parasites and
fungi [39,40,41,42,43]. For these reasons, we extended the analysis
of the VGIII group to include extensive mating assays to
determine genotypes associated with high fertility. Additionally,
sequenced and characterized the C. gattii VGIII MAT locus alleles.
These findings expand on previous studies of the Cryptococcus MAT
locus [44,45,46,47,48] yielding new insights into plasticity of this
genomic region involving rearrangements, gene truncation, and
loss, which may impact fertility.
While previous studies have shown C. gattii is highly virulent in
mice, the focus has been on genotypes causing disease in otherwise
healthy hosts [16,49,50], with no studies to date comprehensively
examining virulence of VGIII. Here we examined murine
virulence and macrophage intracellular proliferation for both the
VGIIIa and VGIIIb. The isolates were also selected based on
mating type criteria to examine what roles, if any, the MAT locus
plays in VGIII virulence. This was of interest, as previous studies
have shown virulence differences in C. neoformans congenic isolates
that differ only at MAT [51,52]. Our results demonstrate the
VGIIIa lineage has increased levels of virulence compared to
VGIIIb.
Our studies reveal a complex population structure within the
highly fertile VGIII molecular type, suggesting recombination in
both the United States and globally via opposite and/or same-sex
mating. We posit that genetic exchange and the formation of
infectious spores may be contributing to an underlying endemic
level of C. gattii infections in southern California. Additionally, we
show that these isolates are virulent in both murine and
macrophage infection models [10]. Overall, the VGIII isolates
from HIV/AIDS patients show decreased levels of virulence in
comparison to the Pacific Northwest outbreak VGII isolates. This
study highlights the need for isolate typing at a resolution sufficient
to distinguish both species and molecular type. Accurate isolate
identification will advance understanding of the epidemiology,
ecology, and health burden of this emerging pathogen, with
potential prognostic and therapeutic benefits for the clinical
management of cryptococcal infections.
Results
Molecular type VGIII forms two distinct lineages that are
the predominant cause of C. gattii infection in a southern
Californian AIDS patient cohort
To characterize the molecular type of C. gattii isolates collected
from the southern California C. gattii cohort [22], we applied
multilocus sequence typing (MLST) analysis at eight unlinked
genomic loci. In total, the patient cohort consisted of 30 isolates.
Of these, one was VGI (3.3%), another isolate was VGII (3.3%),
and the remaining 28 isolates were molecular type VGIII (93.3%).
Examination of the 28 VGIII isolates revealed a high level of
diversity (13 unique genotypes based on seven MLST markers),
isolates of the two mating types (a and a) (Figure 1), and no
evidence for heterozygosity (consistent with FACS analysis
showing they are haploid, data not shown). There are two
genetically distinct groups within the VGIII molecular type. One
was termed VGIIIa (predominantly orange shading in Figures 1,
2), and the other termed VGIIIb (predominantly green shading in
Figures 1, 2). Additionally, two diploid isolates from the cohort
(CA1388 and CA2355) were excluded due to high levels of
heterozygosity in the majority of sequences, indicating they are
likely hybrids. Hybrids between C. neoformans and C. gattii have
been previously reported [53] (see discussion).
To further examine the isolates, their MLST profiles were
compared to an additional 32 VGIII isolates collected from
multiple locations and sources (Figure 2). Based on an examination
of 60 VGIII isolates, the VGIIIa and VGIIIb clusters form two
distinct groups. While many alleles were VGIIIa or VGIIIb
specific, several were shared. Alleles shared between VGIIIa and
VGIIIb are colored in fuchsia (Figures 1 and 2). In the VGIIIa
cluster, all isolates originate from North America and Australia,
while in the VGIIIb cluster, isolates originate from North
America, South America, and Asia (Figure 2). Thus while there
are possible geographic niches for each individual group, some
geographic regions (Mexico and the US) harbor isolates from both
groups. This finding suggests that in at least North America, the
two groups might occupy similar environmental niches with
potential for cross-hybridization.
We next examined the distribution of the sequence types by
constructing maximum likelihood (ML) dendrograms (Figure 3A).
This analysis also supports two distinct clusters. In total, 28
Author Summary
Infections that were once uncommon have become
considerable public health threats due to the increased
number of patients with weakened immunity, including a
large HIV infected population. Among the emerging
infections in the HIV/AIDS population are those caused
by fungi. Fungi are distinct from viral or bacterial
pathogens and often cause skin (athletes foot), mouth
(thrush), or vaginal (yeast) infections. Life-threatening
infections of the lungs and brain are caused by Crypto-
coccus, which infects .1,000,000 patients annually causing
,1/3 of all AIDS-related deaths. Many infections are
caused by C. neoformans, but the sibling species C. gattii
infects both healthy individuals and HIV/AIDS patients and
is causing an outbreak in the Pacific Northwest. Often,
Cryptococcus is not identified at the species level, and C.
gattii may therefore be more common than appreciated.
We studied C. gattii isolates infecting HIV/AIDS patients in
southern California and found they are unrelated to those
causing the Pacific Northwest outbreak (molecular type
VGIII rather than VGII). We show that within VGIII there are
two subgroups, and one is more virulent than the other in
animals. Our studies establish a foundation for research on
C. gattii in HIV/AIDS patients. Given the global magnitude
of infections, these findings have significant public health
implications.
C. gattii in Californian HIV/AIDS Patients
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VGIIIa and 16 in VGIIIb. One VGIIIa genotype, ST28, is an
intermediate between the two subgroups, and consists of two
clinical isolates from Mexico (97/426 and 97/427). This sequence
type harbors two alleles shared between the two groups, two alleles
common and exclusive to the VGIIIa group, and four alleles
unique to this sequence type. The ancestry of this isolate remains
unclear; however, both ST28 isolates originate from Mexico, a
region that harbors isolates of both VGIIIa and VGIIIb, and thus
these isolates may represent VGIIIa/VGIIIb hybrids.
The global population was examined by constructing Neighbor
Joining phylograms (Figure 3B, Figure S1). This analysis also
illustrates two defined lineages, with the ST28 genotype
representing a VGIIIa/b intermediate. Bootstrap support for the
separation of the VGIIIb lineage from the other genotypes is
robust (100) (Figure 3B). Support for all VGIIIa genotypes other
than ST28 is at a level of 86, indicating that ST28 may be a
distinct lineage, or conversely be a divergent genotype within the
VGIIIa lineage (Figure 3B). To address the ancestry of the VGIII
subgroups, we examined the isolates in the context of the three
other C. gattii molecular types (VGI, VGII, VGIV) (Figure S1).
From this analysis, there is strong support (bootstrap value of 100)
that the VGIIIa subgroup is ancestral to the VGIIIb subgroup,
with ST28 as the closest genotype to the VGIIIb clade (Figure S1).
While the two clusters (VGIIIa/VGIIIb) are distinct from one
another, when compared with VGI, VGII, VGIV, all 60 VGIII
isolates lie within the VGIII lineage, clearly delineated from the
other molecular types with a bootstrap support of 100 (Figure S1).
Speciation dynamics and evidence for recombination in
the global VGIII population
Based on an examination of the 60 total isolates, the VGIIIa
and VGIIIb clusters may represent early speciation. To address
aspects of the evolutionary history of the groups, haplotype
network analysis was applied using TCS phylogenetic estimation
for allele ancestry and evolution. The primary alleles focused on in
this analysis were those shared between the subgroups. This
examination addresses if shared alleles have a probable ancestral
origin, or conversely if they were more recently introgressed. Of
the shared alleles, SXI2a was not informative as there is only one
allele. For the other three loci (CAP10, TEF1, PLB1), TCS analysis
revealed that the CAP10 locus and TEF1 locus shared alleles
appear ancestral, while the most parsimonious hypothesis is that
the PLB1 shared allele was introgressed between VGIIIa and
VGIIIb because another allele (PLB1-20) is assigned as the
ancestral root (Figure 4A–C).
In addition to markers encompassing shared alleles, haplotype
networks were also constructed to examine the evolutionary
history of the remaining five markers (Figure S2). For this analysis,
four of the five markers (LAC1, MPD1, GPD1, and IGS) showed
that the VGIIIa and VGIIIb subgroups are separated (Figure S2).
This provides additional evidence for genetic isolation. The
Figure 1. Molecular analysis of isolates from the Californian patient cohort reveals 93% are VGIII molecular type and genetically
diverse. Multilocus sequence typing analysis of eight loci for the 30 isolates of C. gattii from the southern California AIDS patient cohort. Unique
alleles are colored differently for each marker for visual discrimination, and each number represents a GenBank accession number (Table S4). Orange
coloration represents VGIIIa, green VGIIIb, and fuchsia shared alleles. In total, a single isolate is VGI, a single isolate is VGII, and 28 isolates are VGIII
molecular type.
doi:10.1371/journal.ppat.1002205.g001
C. gattii in Californian HIV/AIDS Patients
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history is less well resolved, and shared introgressed alleles may
remain to be discovered in the population (Figure S2). This marker
is highly variable and many of the proposed intermediates have
not been found to date. This could be the result of: 1) under-
sampling of isolates, 2) missing alleles that are either no longer
extant in the population or never existed in cases where mutations
occurred simultaneously, or 3) recombination within the allele.
Overall, this analysis supports a genetic separation, with several
hypothesized but likely rare introgression events having occurred.
Figure 2. Global analysis of molecular markers illustrates high diversity and two distinct VGIII lineages: VGIIIa and VGIIIb. Multilocus
sequence typing analysis was conducted at eight loci for the global collection of 60 VGIII molecular type isolates. Geographic origins of isolates are
indicated, with red indicating isolates from the southern California patient cohort. Unique alleles were assigned distinct colors for each marker for
visual discrimination, and each number represents a GenBank accession number (Table S4). Orange coloration represents VGIIIa, green VGIIIb, and
fuchsia shared alleles.
doi:10.1371/journal.ppat.1002205.g002
C. gattii in Californian HIV/AIDS Patients
PLoS Pathogens | www.plospathogens.org 4 September 2011 | Volume 7 | Issue 9 | e1002205Figure 3. Clustering and phylogenetic analyses of global VGIII isolates reveals two well-supported lineages and one intermediate
genotype. A) A clustering analysis representation (ML) of the concatenated sequence data from global isolates, with the exclusion of MAT locus
linked markers (SXI1a/SXI2a). B) A phylogenetic representation (NJ) and supporting bootstrap values of the sequence data from global isolates, with
the exclusion of MAT locus linked markers (SXI1a/SXI2a). In total, 28 unique sequence types were observed. Details of isolates within each sequence
type are presented in Table S5.
doi:10.1371/journal.ppat.1002205.g003
Figure 4. Haplotype mapping of markers harboring shared alleles between VGIIIa and VGIIIb shows evidence for both ancestral
origins and introgression of shared alleles. Alleles for each respective locus are indicated numerically. Orange coloration represents VGIIIa,
green VGIIIb, and fuchsia shared alleles. Circles represent alleles extant in the population, and the smaller black circles represent alleles that have not
been recovered, or which may no longer be extant in the population. Each line connected to an object represents one postulated evolutionary event,
with the squared allele representing the posited ancestral allele. A–C) Haplotype networks for CAP10, TEF1, and PLB1, respectively.
doi:10.1371/journal.ppat.1002205.g004
C. gattii in Californian HIV/AIDS Patients
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to population structure, we conducted a paired allele analysis
among the global genotypes (Figure 5, Figure S3). The discovery
of all four possible allele combinations between two unlinked loci
(AB, ab, Ab, aB), in the absence of parallel mutations, serves as
evidence for recombination [54,55]. In total, 18 of 28 different
molecular marker pairs showed evidence for recombination, with
25 examples in which all four allele combinations were observed.
To further classify the analysis of the VGIIIa and VGIIIb
subgroups, we examined how frequently allele combinations
indicating recombination were associated with a specific lineage.
In total, 1/25 locus pairs involved only the VGIIIa lineage,
whereas 20/25 pairs involved only the VGIIIb lineage; the four
remaining pairs involved shared alleles. Of the four pairs involving
shared alleles, two involved shared and VGIIIa alleles and two
involved shared and VGIIIb alleles. No pairs contained both
VGIIIa and VGIIIb unique alleles (Figure 5, Figure S3). These
studies demonstrate that while recombination may be present
within both subgroups, the VGIIIb subgroup may be more
actively undergoing recombination in its environmental niche.
To further characterize the role recombination may play in
population structure, we employed MultiLocus software to
examine the percentages of compatible loci and indices of
association (IA). These analyses were completed for the global
population, and also individually for the VGIIIa and VGIIIb
subgroups. Additionally, the dataset was analyzed using all 60
isolates, and then was analyzed as a clone-corrected set with only
unique genotypes represented (n=28). Clone correction is
commonly used to examine fungal populations that are known
to often undergo asexual reproduction and clonal blooms, with less
frequent sexual reproduction and meiosis [56]. The analysis of
both the percentage of compatible loci and IA produce p-values
that if significant reject the null hypothesis of recombination. If the
p-values are not significant, the null hypothesis cannot be rejected
and recombination can be inferred. The analysis illustrates that
although the null hypothesis is rejected in the analysis of all
isolates, VGIIIa individual, VGIIIb individual, and the overall
clone corrected dataset, the null hypothesis cannot be rejected in
the analysis of the individual VGIIIa and VGIIIb subgroups when
the dataset is clone corrected (Table 1). As we cannot reject the
null hypothesis for recombination in the clone corrected subgroup
analysis, it suggests recombination may be occurring within each
subgroup. These results support the hypothesis of active
recombination within the VGIII molecular type and that these
events more likely occur between isolates within the same
subgroup, rather than between subgroups, similar to studies
supporting recombination in VGI and VGII populations in
Australia [35,36].
In addition to population-based studies, we conducted extensive
mating assays among VGIII isolates, showing highly fertile isolates
from both subgroups. In total, 182 mating pairs were examined by
laboratory mating assays, including all eight mating type a isolates,
and representatives from each of the a genotypes. When observed
via light microscopy, 138 pairs showed no signs of fertility, while
44 pairs were able to undergo sexual reproduction, with
representative high resolution SEM imaging of a VGIII6VGIII
cross (NIH3126B4546) shown in Figure 6 (see also Tables 2 and
S1). The SEM imaging, similar to previous studies [32], illustrated
key hallmarks of mating including hyphae, fused clamp cells,
basidia, and elongated basidiospores (Figure 6). When the strains
that were fertile with the greatest number of mating partners were
separated into the top four from each respective mating type, three
of four from both mating types are from the VGIIIb subgroup
(Table S1). This shows that while both groups are fertile, levels of
fertility (based on the number of fertile partners) may be higher in
the VGIIIb subgroup, consistent with the increased number of
unique VGIIIb genotypes (n=16 out of 27 isolates or 59%)
compared to VGIIIa (n=12 out of 33 isolates or 36%). Overall, a
higher percentage of a isolates are fertile compared to a isolates
(Table 2). When both mating types are combined VGIIIb shows
an increased percentage of fertile isolates compared to VGIIIa
(Table 2). These findings support the hypothesis that mating may
also occur in the environment.
Characterization of the VGIII MAT locus alleles illustrates
distinct features
Sequencing of the a and a MAT locus alleles from two
representative strains of the VGIII lineage shows that overall, the
general structure, size, and characteristics are similar to previously
sequenced C. gattii VGI and VGII MAT loci (Figure 7). Both
SXI1a or SXI2a and the pheromone receptor and pheromone
genes are present in the MAT locus, further supporting that C. gattii
VGIII has a bipolar mating system.
Although there are marked similarities for the MAT locus alleles
of VGI/VGII with VGIII, there are also distinct characteristics for
each VGIII MAT allele. There are two rearrangements in the
MATa allele 39 region compared to the VGI isolate E566.
Moreover, a partial deletion of UAP1 and loss of the FCY1 and
FAO1 genes from the VGIII MATa allele 59 flanking region was
identified via sequencing of the VGIII a isolate B4546 and
confirmed to be present in all eight VGIII a isolates examined,
although no phenotypic consequences were observed (Figures 7,
S4, and S5). Southern blot analysis of FCY1 and PCR analysis of
all three full length genes with primers selected based on regions
conserved between C. neoformans and C. gattii shows that they might
not be present in the genome, or alternatively that they are rapidly
evolving and too diverged to hybridize with probes and primers
used (Figure S5). All isolates remain sensitive to the antifungal
agent 5-Fluorocytosine (5-FC) indicating that the FCY1 gene is
functioning or that another gene acts in a similar manner.
Additionally, an ,1.1 kb truncation of the FAO1 gene, a putative
iron oxidoreductase, was found in all VGIII a strains analyzed.
Using PCR, we could not detect an intact FAO1 gene elsewhere in
the genome of the VGIII a isolates. Four pheromone gene copies
were previously found within the VGII and VGI MATa loci,
arranged in two pairs of divergently oriented, linked genes.
However, although VGIII has been shown to be more fertile than
VGI/VGII, based on the sequence assembly for strain NIH312,
we found only two copies of the MFa pheromone gene, although
one gap remains in this region of the locus. Additionally, we
discovered a remnant of the a specific gene SXI2a in the VGIIIa
mating type locus, and through sequence comparisons show that it
is present in C. gattii molecular types VGI, VGII, and VGIII, but
not present in C. neoformans var. neoformans (serotype D) or C.
neoformans var. grubii serotype A (Figure S6).
Fingerprinting analysis of the MAT locus alleles revealed no size
polymorphisms within MAT for VGIII a isolates, but did reveal
diversity within the a allele (Figure 7, Table S2). Distinct alleles for
fingerprint products 9 and 18 of the a locus, were identified that
are correlated with the VGIIIa and VGIIIb molecular types
(Figures 7, Table S2). Additionally, a 120 bp polymorphism within
the CID1 and LPD1 intergenic sequence (fingerprint 8 of the a
locus) was correlated with VGIIIa and VGIIIb molecular types
with the exception of one VGIIIb strain harboring the SXIa allele
38, which contained the VGIIIa genotype at this region and could
reflect recombination within MAT as a result of a-a mating
(Figure 7, Table S2). Other VGIII isolates with SXI1a allele 38
were also confirmed to have this genotype (data not shown) and
C. gattii in Californian HIV/AIDS Patients
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were not correlated with the subgroups.
Virulence and histopathology
To address the virulence characteristics of the VGIII isolates,
and correlate these with genotype and mating type, we conducted
murine intranasal instillation challenges. In total, we chose 11
isolates from the patient cohort and one environmental VGIII
control strain isolated in San Diego, California from an E.
camaldulensis tree in 1992 [57]. Of the eleven clinical isolates, six
were from the VGIIIa subgroup and five from the VGIIIb
subgroup, with eight a and three a isolates (Figure 8A). Of the
isolates examined, CA1499 was more virulent than all other
isolates tested (Figure 8A). Additionally, when we compared
overall virulence between the two subgroups, the VGIIIa
subgroup showed a significantly higher mortality rate when
compared to the VGIIIb subgroup (p,0.025). When isolate
CA1089 was excluded from this analysis, the support increased
(p,0.005). These results suggest that the molecular differentiation
between the two lineages within VGIII is associated with a
dichotomy in murine mortality post cryptococcal infection. We
also show that the environmental isolate WM161 (VGIIIa) was less
virulent than the five clinical VGIIIa isolates, but more virulent
than all of the VGIIIb isolates. Isolates with increased levels of
mortality were also found to be associated with rapid declines in
total body weight during the course of infection (Figure 8B).
Histological examinations of lung tissues from mice infected
with the highly virulent C. gattii strain CA1499 revealed
widespread dissemination of cryptococci throughout the alveoli
and airways with little to no inflammatory response. The
expansion of alveoli with confluent clusters of budding yeasts
and breakdown of alveolar walls were seen (Figure 9A–9B). The
lungs of mice infected with strain CA1292 (moderate virulence)
also revealed minimum inflammation with alveoli engorged with
rapidly dividing yeasts. Also evident were a few alveoli with one to
two C. gattii yeasts. Despite rapid multiplication, this strain
appeared to be less disseminated as some of the alveoli and
airways were devoid of any yeast cells (Figure 9C–9D). In contrast,
lungs of mice infected with the low virulence strain WM161
revealed influx of inflammatory response surrounding infected
alveoli and airways. The majority of the infected alveoli contained
only one to two yeasts with a few alveoli containing three or four
yeasts (Figure 9E–9F). No yeast cells were seen in any of the lung
sections of mice infected with avirulent strain CA2339; however,
vigorous tissue response in the form of neutrophil influx was
observed throughout the lung section (Figure 9G–9H). The brain
sections of all infected mice did not reveal any apparent lesions
except for the highly virulent strain (CA1499), which showed
occasional single or budding yeasts on the meninges (data not
shown).
Although there were some differences in the dissemination
pattern of CA1499 (high virulence) and CA1292 (moderate
virulence) by histopathology, the quantification of yeasts from
infected lungs at weekly intervals did not reveal any significant
difference (Figure 10). This could be due to heavy colonization by
Figure 5. Evidence for genetic recombination within the VGIII
population, particularly within alleles unique to the VGIIIa
lineage. Informative paired allele graphs from VGIII global isolates. An
hourglass shape indicates the presence of all four possible pairs of
alleles and serves as evidence of recombination. A) An example of
recombination evidence within VGIIIb (top) and VGIIIa (bottom). B) An
example of recombination evidence within VGIIIb unique alleles (top)
and an example involving a shared allele and three VGIIIa unique alleles
(bottom). C) An example of recombination evidence involving both
shared and VGIIIb unique alleles. All of the informative paired allele
graphs constructed for this analysis can be found in Figure S3.
doi:10.1371/journal.ppat.1002205.g005
C. gattii in Californian HIV/AIDS Patients
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organ loads of these two strains were compared with that of lung
organ load of mice infected with low virulent strain WM161, the
results were statistically significant (P,0.05). In comparison, the
avirulent strain was cleared rapidly by one week post-infection and
was not found in the lungs at two weeks post-infection (Figure 10).
Overall, these results indicated that C. gattii rapid multiplication,
dissemination, and invasion of the host defense of the lungs dictate
the outcome of pulmonary cryptococcosis. Only small numbers of
yeasts were recovered from brain cultures of mice infected with
virulent strains of C. gattii (data not shown). These results indicated
that pulmonary cryptococcosis and not CNS dissemination was
the primary disease manifestation in this model and the likely
cause of mice mortality observed (Figure 8).
Intracellular proliferation rates (IPRs) were determined for each
strain examined in the murine model of infection. This assay is
correlated positively with murine virulence, based on previous
studies Pacific Northwest outbreak isolates [10,49]. To further
Table 1. Recombination analysis of the global VGIII population.
Population n
Percent
compatible loci
Percent compatible
loci p value
Index of
Association
Index of Association
p value
All 60 0.29 ,0.01 2.66 ,0.01
VGIIIa 33 0.86 ,0.01 0.67 ,0.01
VGIIIb 27 0.38 ,0.01 0.45 ,0.01
All clone corrected 28 0.29 ,0.01 1.78 ,0.01
VGIIIa clone corrected 12 0.86 0.53 20.01 0.47
VGIIIb clone corrected 16 0.38 0.72 0.13 0.28
doi:10.1371/journal.ppat.1002205.t001
Figure 6. Scanning electron microscopy imaging of two VGIIIb isolates undergoing a-a mating to produce spores. Mating images are
of NIH312a6B4546a from a V8 media (pH=5) mating assay. A) Imaging of yeast cells, hyphae, and a clamp cell (arrow) (7,5006). B) Representation of
yeast cells and hyphae, with an emerging bud seen to the left of the panel and a blastospore forming off of the hyphae (arrow, 7,0006). C) Yeast,
hyphae, basidia, and basidiospores. One detached spore is seen in the top left of the panel, and is characteristically elongated (6,0006). D) A high
magnification image of a single basidium with four emerging basidiospores (10,0006). All scale bars are 3 mm.
doi:10.1371/journal.ppat.1002205.g006
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intracellular proliferation of cells within macrophages was directly
tested for the seven VGIIIa and five VGIIIb isolates that were
examined in the mouse model (Figure 11 A–B). Similar to the
murine experiments, the VGIIIa subgroup showed significantly
higher IPR levels than the VGIIIb subgroup (p,0.005, Figure 11
A, C). Additionally, as in the previous studies, IPR values and
survival time in vivo showed strongly positive correlations upon
regression analysis (Figure 11 B, D). A single VGIIIa isolate,
CA1089, was an outlier with high IPR but low virulence.
Therefore, the regression analysis was conducted both with
(Figure 11 A, B) and without this isolate (Figure 11 C, D). While
the significance levels were better supported when CA1089 was
excluded, they were statistically significant in both cases (Figure 11
B, D). The IPR analysis combined with the in vivo model shows
that the isolates from the Californian patient cohort show
virulence differences in which the VGIIIa subgroup was more
virulent overall than the VGIIIb subgroup.
Discussion
Globally the burden of cryptococcal disease is significant with
approximately one million annual cases [19]. Although .99% of
AIDS related infections and .95% of overall cases are attributed
to C. neoformans serotype A [1], C. gattii also has been shown to
cause disease among AIDS patients in both sub-Saharan Africa
and the US [18,22]. In the study of Litvintseva et al., an African
AIDS cohort was found to be infected with C. gattii serotype C
VGIV molecular type [18]. Here C. gattii isolates were examined
from a previously reported HIV/AIDS patient cohort in southern
California [22], and found to be almost exclusively (93%) VGIII
molecular type. The finding of C. gattii VGIII and VGIV isolates
associated with HIV/AIDS patients is in stark contrast to
numerous C. gattii infections among immunocompetent individuals
caused by VGI/VGII isolates, and the ongoing VGII outbreak in
the North American Pacific Northwest [5,7,9,10,16,58,59,60,
61,62].
The Californian HIV/AIDS patient cohort C. gattii strains were
analyzed in the context of a global VGIII isolate collection to
further characterize this molecular type. Analysis of 60 isolates at
eight loci resolved two distinct subgroups designated VGIIIa and
VGIIIb. In contrast to the Pacific Northwest VGII outbreak that is
largely clonal with one genotype causing the majority of illness
[9,10,16,63], based on analysis of seven non sex-linked loci we
found a total of 13 unique genotypes in the 28 VGIII isolates from
the Californian patients. This increased level of diversity suggests
this molecular type was introduced into the region longer ago than
the VGII lineage to the Pacific Northwest, or alternatively that the
VGIII population in California is more rapidly diverging. Our
studies, in addition to a recent study documenting VGIII isolates
in Mexico, lead to the hypothesis that the VGIII molecular type
may be endemic to a large area of western North America [16,31].
These findings are significant, as there may be unrecognized cases
of C. gattii among HIV/AIDS patients.
Phylogenetic analysis of the molecular types revealed that
VGIIIa is basal to VGIIIb (Figure S1). Given that VGIIIa is more
virulent in mice and murine macrophages, it may be that VGIIIb
has become more specialized to infect hosts with increased
susceptibility to infections. It currently remains unclear as to
whether these two groups have naturally evolved to display
differences in virulence or if there is some form of selection.
Regardless, increased surveillance of VGIII cases, aided by clinical
studies to determine the types of infection each group causes,
should shed further light as to whether these two groups also have
distinct clinical features. Clustering and phylogenetic analyses of
the VGIII global collection revealed 28 unique genotypes among
60 isolates. Subsequent phylogenetic analysis revealed that the two
observed groups were indeed well supported lineages. Haplotype
mapping was then conducted, supporting the discrimination into
VGIIIa and VGIIIb. Additionally, the mapping of markers
harboring shared alleles between the subgroups revealed that
two of the three shared alleles are ancestral in origin, while one
may result from introgression between VGIIIa and VGIIIb. This
type of introgression event is not unprecedented between distinct
lineages, cryptic species, or species within the fungal kingdom,
with examples from model fungi and both plant and animal
pathogens [64,65,66,67].
The ability for microbial pathogens to undergo sexual
reproduction involving meiosis is unique to the eukaryotic lineage,
including the parasites and fungi. Sex may play a significant role in
several aspects of pathogenesis, including the generation of genetic
diversity, the formation of invasive hyphae or spores, and direct
links between the mating type locus and mating pathways with
virulence [34,35,37,39,52,68,69,70,71,72,73,74,75,76]. For these
reasons, and to understand the population dynamics of VGIII, we
conducted two types of recombination analyses: informative
paired allele graphs and statistical analyses of percentages of
compatible loci and IA. Our analyses support the hypothesis of
recombination within the distinctive VGIII subgroups. This is
consistent with the observed molecular differences between the
two groups. Our population results, taken together with an
increased number of highly fertile VGIIIb isolates in comparison
to VGIIIa, suggest that the VGIIIb group may be more actively
recombining. Furthermore, the two excluded hybrid isolates
appear to be C. neoformans var. neoformans/C. gattii molecular type
VGIIIb hybrids (based on the GPD1 MLST allele specifically
amplifying C. gattii sequence and the IGS allele specifically
amplifying C. neoformans sequence, while the other MLST loci
were highly heterozygous). The enhanced fertility ofn the VGIIIb
subgroup may contribute to hybridization with C. neoformans.
The ability to undergo sexual reproduction also has implications
for the formation of infectious spores. Recent studies show that
spores can initiate disseminated cryptococcal disease in the murine
inhalation model of infection [34,37]. Laboratory studies have also
shown that Cryptococcus can complete a full sexual cycle in
association with plants, leading to the production of infectious
spores [77]. It has been previously shown that the VGIII lineage
shows high levels of fertility [32] and our examination of
compatible isolate pairs supports that mating and spore formation
may play a significant role in the formation of small aerosolized
particles that could be readily inhaled. Furthermore, in California,
Table 2. Fertility of VGIIIa and VGIIIb lineages.
Lineage Mating-type # Fertile/total % Fertile
VGIIIa a 1/1 100
VGIIIa a 10/32 31
VGIIIb a 7/7 100
VGIIIb a 10/20 50
All Isolates a 8/8 100
All Isolates a 20/52 38
VGIIIa a+a 11/33 33
VGIIIb a+a 17/27 63
doi:10.1371/journal.ppat.1002205.t002
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under laboratory conditions.
The MAT alleles of C. gattii molecular types VGI and VGII are
highly conserved, based on both DNA sequence similarity and
gene synteny [48]. The sequenced MATa locus alleles of VGI
WM276, VGII R265, and VGIII NIH312 share full synteny
(Figure 7). A comparison of the three loci reveals only expansions,
contractions, and translocation of intergenic sequences, which
account for the majority of the structural variation. Additionally,
there is also a truncation of the FAO1 gene in all VGIII a isolates
examined. The sequenced MATa locus alleles of VGI E566 and
VGIII B4546 show a higher degree of rearrangement in
comparison to MATa (Figure 7). Additionally, a partial deletion
of the UAP1 gene, along with a complete deletion of the FCY1 and
Figure 7. The VGIII MAT locus of a and a strains share relative synteny with other molecular types but also show rearrangements in
MATa. A) The MATa locus and flanking regions of molecular type VGIII compared to the locus of molecular type VGI. Fingerprint markers are shown
with the order of strains from left to right as follows: B4546, CA1227, CA1232, CA1277, CA1508, CA1873, ICB108, and ATCC32608. B) The MATa locus
and flanking regions of molecular type VGIII compared to the loci of molecular types VGI and VGII. Fingerprint markers are shown with the order of
strains from left to right as follows: ICB88, DUMC140.97, CA1280, CA1093, NIH836 NIH312, CA1700, MMC08-897, WM161, MEX240, CA1514, 97/426,
97/433, and 97/428. The scale bar is equal to 10 kb and applies to both MAT locus alleles. Shading indicated the boundaries of the MAT locus alleles.
doi:10.1371/journal.ppat.1002205.g007
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the VGIII a population. UAP1 is predicted to encode a candidate
uric acid transporter whose closest homolog is the A. nidulans uapA
gene [78,79,80] and Fcy1 is a cytosine deaminase that has been
shown to confer resistance to 5-FC when deleted in C. albicans, S.
cerevisiae, and C. neoformans [81,82]. Although both PCR and
southern blot analyses could not detect a copy of the FCY1 gene in
the genome of the VGIII MATa isolates, phenotypic tests showed
these isolates remain sensitive to 5-FC and they may therefore
harbor a more diverged FCY1 gene elsewhere in the genome.
Phenotypic assays on media with uric acid as a sole nitrogen
source to examine the possible loss of UAP1 also showed no
Figure 8. Isolates from the VGIIIa group exhibit increased virulence compared to VGIIIb in an in vivo murine model of infection. A)
Groups of five animals were each infected with an infectious inoculum of 1.0610
5 cells, and the survival of animals plotted against days post-
infection. The legend is arranged from most virulent (top) to least virulent (bottom, based on survival). VGIIIa isolates are indicated by orange
coloration and VGIIIb isolates are indicated by green coloration. B) C. gattii infections cause notable weight loss associated with the virulence level of
strains. BALB/c mice were infected with 1.0610
5 yeast cells via the intranasal instillation route. The weight of each animal was monitored every other
day after infection while asymptomatic. When the animals began to exhibit symptoms of infection, weight was measured daily and plotted.
doi:10.1371/journal.ppat.1002205.g008
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5 yeast cells via intranasal
instillation. The infected lungs were harvested at two weeks post-infection and processed as described above. Note that airway (arrow, A) and all the
alveoli (double arrow, A) were packed with rapidly dividing yeasts with minimum tissue response (white arrow, B) in mice infected with highly
virulent strain CA1499, while moderately virulent strain CA1292 showed a similar pattern except that several empty alveoli surrounding infected
alveoli were observed (C, D). In contrast, the low virulene strain WM161 revealed less multiplication of C. gattii with a majority of alveoli containing
one or two yeasts with an influx of inflammatory response (E, F). No yeast was seen in the lungs of mice infected with avirulent strain CA2339 and a
vigorous inflammatory response was visible throughout the lung section (G, H). (Mucicarmine and H & E staining, 6100 magnification, scale bar
50 uM).
doi:10.1371/journal.ppat.1002205.g009
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to efficiently grow (data not shown). Based on findings in C.
neoformans, recombination hotspots may flank the MAT locus alleles
and thus have contributed to the flanking region deletions [83].
Overall, analysis of the C. gattii MAT locus alleles showed a more
dynamic MATa locus compared to the a locus. Given the
significant rearrangement of the MATa locus, and the deletion or
exclusion of genes from the locus and flanking region, it appears
that the VGIII MATa population has experienced increased
genetic variation. Deletion or exclusion of genes from the MAT
locus and flanking regions may be an indication of expansion or
contraction of the VGIII MATa locus. The finding of a SXI2a
remnant conserved in C. gattii may signal a previous tetrapolar
mating type state, consistent with the prevailing models and studies
in related Cryptococcus species (Figure S6 B) [46,47,48,84,85], or
result from a C. gattii lineage specific gene conversion of SXI2a into
the a allele (Figure S6 C). Alternatively, this remnant may be
functional and influence mating.
Within VGIII, fingerprinting analysis revealed a monomorphic
MATa allele and a mostly biallelic MATa locus correlating with
the VGIIIa and VGIIIb lineages. Two fingerprints revealed size
polymorphisms correlated with VGIIIa and VGIIIb isolates,
serving as additional evidence for ongoing genetic separation
between these two groups. VGIIIb strains harboring SXIa allele 38
contained the VGIIIa genotype for the intergenic sequence
between CID1 and LPD1, suggesting that these strains harbor
either the ancestral VGIII MATa allele or contain a hybrid MATa
locus that may be the result of a gene introgression event between
the two groups or a recombination event between same-sex
isolates of opposite VGIII lineages (i.e., VGIIIa/VGIIIb).
However, an additional polymorphic marker within the MATa
locus is needed to address the latter hypothesis.
Following the definition of two well-supported lineages
including isolates from both mating types, we examined virulence
characteristics associated with these properties. We found
significant differences between phylogenetic subgroups. In both
whole animal murine in vivo intranasal instillation and prolifer-
ation assays in murine derived macrophages, the VGIIIa subgroup
is more virulent than the VGIIIb subgroup. These findings are
significant and serve as a foundation for future studies to
determine the molecular basis for these observed phenotypes.
Additionally, from a public health and epidemiological standpoint,
it may be useful to determine if isolates are VGIIIa or VGIIIb.
Clinical studies would have to be conducted in coordination to
ascertain if the molecular subgroup is associated with altered
clinical manifestations or outcomes. Based on the histological
examinations, our findings indicate that host tissue responses in
combination with yeast cell multiplication and capsule induction
are associated with the outcome of pulmonary cryptococcosis,
similar to previous studies documenting that upon serial in vivo
passage of C. neoformans, strains increase in virulence with an
associated decrease in capsule size [86].
Our study provides a comprehensive molecular and phenotypic
overview of the C. gattii VGIII molecular type, which has
historically been less studied than both the VGI and VGII
molecular types. Our findings support two distinct lineages that
might each be recombining, with the VGIIIa lineage showing
higher levels of virulence in the models examined. Of significance,
Figure 10. C. gattii organ load determination. Male, BALB/c mice were infected intranasally with 1610
5 C. gattii yeast cells intranasally. After one
and two weeks post-infection, lungs and brains from three infected mice were removed asceptically and fungal load was determined by CFU
enumeration as described in materials and methods. The bar diagram represents mean 6 SD of CFU per gram of lung tissues obtained from three
mice each for different C. gattii strains.
doi:10.1371/journal.ppat.1002205.g010
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patients in southern California. The high level of VGIII observed
is in stark contrast to the Pacific Northwest VGII outbreak of
VGII, in which the vast majority of cases reported are not
associated with HIV/AIDS infected patients [7,9,10,16,63]. This
suggests that C. gattii may occur in two general patient settings:
VGI/VGII in otherwise healthy hosts (.50%) or those treated
with steroids, vs. VGIII/VGIV predominantly in HIV/AIDS
patients. Moreover, C. gattii infections may cause a substantial
unrecognized health burden. To address these aspects, both
retrospective and prospective studies should be conducted to: 1)
survey global isolate collections from HIV/AIDS patients and 2)
assign species and molecular types to newly collected isolates from
HIV/AIDS patients with cryptococcal infections.
Materials and Methods
Phenotypic identification assays
All isolates from southern California and other global isolates
were screened to confirm that they were C. gattii. Melanin
production was assayed by growth and dark pigmentation on
Staib’s niger seed medium; urease activity was detected by growth
and alkaline pH change on Christensen’s agar. These tests
established that isolates were Cryptococcus (C. neoformans or C. gattii).
Additionally, isolates were assayed for resistance to canavanine
and utilization of glycine on L-canavanine, glycine, 2-bromothy-
mol blue (CGB) agar. Growth on CGB agar indicates that isolates
are canavanine resistant, and able to use glycine as a sole carbon
source, triggering a bromothymol blue color reaction indicative of
C. gattii. All CGB positive isolates were then grown under rich
culture conditions prior to genomic DNA extraction and storage at
280uC in 25% glycerol. For genomic DNA isolation, the
MasterPure Yeast DNA purification kit from Epicentre Biotech-
nologies was used.
Multilocus sequence typing
Each VGIII isolate examined in the analysis was subjected to
multilocus sequence typing (MLST) [87] at a total of eight loci
(Table S3). This marker set was selected to include loci that have
been validated in other analyses of C. gattii [7,16,88,89,90]. For
each isolate, genomic regions were PCR amplified, purified
(ExoSAP-IT, Qiagen), and sequenced. Sequences from both
forward and reverse strands were assembled with complete double
strand coverage and manually edited using Sequencher version 4.8
Figure 11. In vitro analysis of intracellular proliferation rates (IPR) show increased proliferation levels in VGIIIa and IPR values
correlate with in vivo virulence. A) IPR values for the 12 isolates examined in mice; orange indicates VGIIIa and green indicates VGIIIb.
B) Regression analysis illustrating a linear correlation of IPR and the time to 50% lethality in mice. C) IPR values for the isolates examined in mice,
CA1089 excluded; orange indicates VGIIIa and green indicated VGIIIb. D) Regression analysis illustrating a linear correlation of IPR and the time to 50%
lethality in mice with isolate CA1089 excluded.
doi:10.1371/journal.ppat.1002205.g011
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GenBank database (NCBI), each allele was assigned a correspond-
ing number, or given a new number if the sequence was not
already in the database. GenBank accession numbers with
corresponding allele numbers are listed in the supplementary
information (Table S4).
Clustering and phylogenetic analyses
For each isolate, a sequence type was defined as a sequence
exhibiting a unique sequence profile, based on concatenation of
the MLST markers. Each sequence type was confirmed to be
unique by BLAST analysis of the NCBI GenBank database [91].
A multiple alignment of the sequences was carried out using
Clustal W software [92]. Clustering analysis of the sequences was
conducted using PhyML, which applies the maximum likelihood
model for analysis [93]. The phylogenetic analysis was conducted
using the Neighbor Joining algorithm. Haplotype network
modeling was conducted using TCS software (version 1.21) [94].
The statistical recombination analysis was completed using
MultiLocus software (version 1.2.2).
Mating assays
Mating assays were conducted on V8 media (pH=5). Isolates
were incubated at room temperature in the dark for 2–4 weeks in
dry conditions. Fertility was assessed by light microscopic
examination for hyphae, fused clamp cells, basidia, and basidio-
spore formation at the periphery and surface of the co-incubated
mating patch. All mating assays were conducted in duplicate. If
there were no signs of fertility after the four-week period, isolate
pairs were scored as having no fertility when paired together.
Scanning Electron Microscopy (SEM)
SEM analysis was completed using protocols similar to those
previously published [34]. Mating cultures (NIH3126B4546) were
excised from V8 medium agar plates and fixed at 4uCi n3 %
glutaraldehyde that was buffered in 0.1 M Na cacodylate
(pH=6.8). Samples were then washed in triplicate using cold
0.1 M Na cacodylate buffer. This was followed by a graded
dehydration series of 1 hr changes in cold 30% and 50% ethanol
and held overnight. Dehydration was completed with 1 hr changes
of cold 95% and 100% ethanol at 4uC and warming to room
temperature in 100% EtOH. Two additional 1 hr changes of
room temperature 100% EtOH completed the dehydration series.
The samples were then critical point dried in liquid CO2 (Samdri-
795; Tousimis Research Corp., Rockville, MD) for 15 min at the
critical point. The agar pieces were mounted and sealed with silver
paint to ensure good conductivity. The samples were sputter
coated with 50 A ˚ of Au/Pd (Hummer 6.2; Anatech U.S.A.,
Hayward, CA). Samples were held under vacuum conditions until
viewed with a Jeol JSM 5900LV scanning electron microscope at
15 kV.
Sequencing and analysis of the MAT locus alleles
The strains used for the construction of the Bacterial Artificial
Chromosome (BAC) and fosmid libraries and analysis of the MAT
locus alleles were NIH312 (MATa) and B4546 (MATa). Isolates
were grown on YPD media at 30uC, and library construction was
performed according to previous studies [48,84]. Sequencing
reactions were performed using BigDye 3.1 (Applied Biosystems,
Foster City, California, United States) and analyzed on an
ABI3100 sequencer. Sequence reads were assembled using the
PHRED/PHRAP/CONSED package [95,96] and Sequencher
4.8 (Gene Codes Corporation). Additional analysis of the data was
performed using BLASTn [91]. Based on the initial assembly of
sequences, oligonucleotides were selected to close gaps in the
sequence coverage by primer walking. Genes on the MAT locus of
C. gattii were annotated based on homology to the existing
annotation in C. gattii VGII (strain R265) and VGI (strains
WM276 and E566), and C. neoformans (H99 and JEC21). Certain
gene annotations were modified using the FGENESH program
(http://linux1.softberry.com/berry.phtml). Comparison of the
MAT locus alleles among VGI, VGII, and VGIII strains was
performed using BLASTn. The BLASTn results were parsed using
a PERL script and imputed into the ACT program to construct
synteny diagrams of the MAT locus alleles among C. gattii strains.
In order to evaluate size polymorphisms within the MAT locus, 14
MATa strains representing all SXI1a alleles and 8 MATa strains
were amplified using primers complementary to conserved
sequences. Primers used for fingerprinting are listed in Table S3.
The PCR products were digested using appropriate enzymes
selected on the basis of DNA sequences using NEBcutter version
2.0 (http://tools.neb.com/NEBcutter2/index.php). Fingerprints
showing variability were sequenced to determine the nature of
any size polymorphisms. Sequences from both forward and reverse
strands were assembled with complete double strand coverage and
manually edited using Sequencher version 4.8 (Gene Codes
Corporation).
Murine virulence assays
The pathogenic potential of C. gattii strains belonging to the
VGIII genotype was tested in a murine model of pulmonary
cryptococcosis [97]. Briefly, C. gattii strains were grown in YPD
broth for 16 hours and washed with sterile physiological saline.
Cells were counted with a hemocytometer and suspended at a
concentration of 3.3610
6 cells/ml. Five male BALB/c mice
(approximately six-weeks old, 15–20 g; Charles River) in each
group were first anesthetized with xylazine-ketamine mixture and
then 30 ul of infectious inocula was gently dripped into their nares.
The injected animals were observed for any overt signs of illness,
and all morbid animals were promptly sacrificed by CO2
inhalation to minimize pain and suffering.
Data from all infected animals were used to determine Kaplan-
Meyer survival curves using SAS software (SAS Institute, Inc.,
Cary, N.C.). For this statistical analysis with genotype information,
the non-parametric Mann-Whitney U-test was applied, with
further details in the statistical analysis section (http://faculty.
vassar.edu/lowry/utest.html). Progression of disease was also
determined by weighing infected animals once every alternate
day at the start of the infection and then every day until they were
moribund. One half portion of the lung and brain tissues from
sacrificed animals was cultured on YPD and Staib’s niger seed
agar for the recovery of cells to determine that infections were
cryptococcal in origin.
Organ load and histopathology
To characterize virulence properties, representative C. gattii
strains from four virulence groups comprising high virulence
strains (CA1499), moderate virulence strains (CA1292), low
virulence strains (WM161), and avirulent strains (CA2339), were
chosen for further intranasal infection per procedure described
previously. A total of six mice were infected for each test strain and
groups of three mice were sacrificed at one and two-weeks post
infection. The lungs and brains were removed aseptically, one half
of each organ was fixed in 10% buffered formalin and Bouin’s
fixative, processed into paraffin blocks, sectioned, and stained with
hematoxylin and eosin (H & E) and Mayer’s mucicarmine for
histopathological examination. The other halves of the lungs and
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YPD agar. Colonies were counted after incubation of the plates at
30uC for 4 days, and the results were expressed as colony forming
unit (CFU) per gram of infected tissue. Results from organ load
experiment were analyzed by student t-test, with significance
determined at P#0.05.
Ethics statement
The animal studies conducted were in full compliance with all of
the guidelines set forth by the Wadsworth Center Institutional
Animal Care and Use Committee (IACUC) and in full compliance
with the United States Animal Welfare Act (Public Law 98–198).
The Wadsworth Center IACUC approved all of the vertebrate
studies. The studies were conducted in facilities accredited by the
Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC).
Intracellular Proliferation Rate (IPR) determination
A proliferation assay was previously developed to monitor the
intracellular proliferation rate ( I P R )o fi n d i v i d u a ls t r a i n s( f o ra
72-hour period) following phagocytosis [49]. For this assay, J774
macrophage cells were exposed to cryptococcal cells that were
opsonized with 18B7 antibody for 2 hr as described previously
[98]. Each well was washed with phosphate-buffered saline
(PBS) in quadruplicate to remove as many extracellular yeast
cells as possible and 1 ml of fresh serum-free DMEM was then
added. For time point T=0, the 1 ml of DMEM was discarded
and 200 mlo fs t e r i l ed H 2O was added into wells to lyse
macrophage cells. After 30 minutes, the intracellular yeast were
released and collected. Another 200 mld H 2O was added to each
well to collect the remaining yeast cells. The intracellular yeast
were then mixed with Trypan Blue at a 1:1 ratio and the live
yeast cells were counted. For the subsequent five time points
(T=18hrs, T=24hrs, T=48hrs, T=72hrs), intracellular
cryptococcal cells were collected and independently counted
with a hemocytometer.
For each strain tested, the time course was repeated at least
three independent times, using different batches of macrophages.
The IPR value was calculated by dividing the maximum
intracellular yeast number by the initial intracellular yeast number
at T=0. We confirmed that Trypan Blue stains 100% of the
cryptococcal cells in a heat-killed culture, but only approximately
5% of cells from a standard overnight culture. Compared to a
conventional colony counting method, this method was shown to
be more sensitive in detecting the clustered yeast population or
yeast cells undergoing budding.
Statistical analysis
Time to 50% lethality (LT50) and median IPR values were
used to assess the statistical significance between the VGIII
subgroups and these respective values. For this statistical
analysis, the non-parametric directional Mann-Whitney U-test
was applied and values of p,0.025 were considered as
statistically significant (http://faculty.vassar.edu/lowry/utest.
html). Regression analysis was used to measure the correlation
between LT50 and IPR values, and an F-value of p,0.05 was
considered to be a significant correlation, with R
2,pv a l u e s ,
and Pearson correlations also calculated and represented in the
analysis.
Strains
All strains used in this study are listed in Table S6, including C.
gattii, C. neoformans, and S. cerevisiae isolates.
Supporting Information
Figure S1 A phylogenetic representation (NJ) and sup-
porting bootstrap values of the sequence data from
global VGIII isolates, with the exclusion of MAT locus
linked markers (SXI1a/SXI2a). VGI, VGII, and VGIV out-
groups are included.
(TIFF)
Figure S2 Additional haplotype networks for MLST
markers not shown in Figure 4. Alleles for each respective
locus are indicated numerically. Orange coloration represents
VGIIIa and green VGIIIb. Circles represent alleles extant in the
population, and the smaller black circles represent alleles that have
not been recovered, or which may no longer be extant in the
population. Each line connected to an object represents one
postulated evolutionary event, with the squared allele representing
the posited ancestral allele.
(TIFF)
Figure S3 Additional informative paired allele graphs
from VGIII global isolates. An hourglass shape indicates the
presence of all four possible pairs of alleles and serves as evidence
of recombination.
(PDF)
Figure S4 Phenotypic analysis of VGIII MATa isolates
related to the loss of the FCY1 gene from the MAT locus.
Results indicate that FCY1 or another gene is still functioning to
retain expected WT phenotypes involving sensitivity to the
antifungal agent 5-Fluorocytosine (5-FC) and utilization of
cytosine as a sole nitrogen source. Control strains include S.
cerevisiae WT (S90) and an fcy1D mutant strain (S109) that is
resistant to 5-FC and unable to utilize cytosine as a sole nitrogen
source, and wild type control strains for C. neoformans var. grubii
(H99) and C. neoformans var. neoformans (JEC21).
(TIFF)
Figure S5 Molecular analysis of VGIII MATa isolates
related to the loss of the FCY1 and FAO1 genes from the
MAT locus and the truncation of the UAP1 gene. A) List of
strains. B) Southern blot analysis results indicate that the FCY1
gene may no longer be present in the genome, or that the gene
may have undergone accelerated evolution and thus not be
detected by hybridization to the probe that is based on the VGIIIa
(NIH312) gene sequence. C) GPD1 control for Southern blot. D–F)
PCR analysis for FCY1, FAO1, and UAP1, respectively, indicating
a loss of the genes from the VGIII MATa genomes, or that the
genes might have undergone accelerated evolution and thus not be
detected with the oligonucleotide primers used.
(TIFF)
Figure S6 Remnant of SXI2a in VGIII a isolates. A) The
grey shading indicates intergenic MAT sequence, while
the black line indicates sequence outside of the MAT
locus allele. The homology of the SXI2a remnant is indicated on
the figure. B) A model for the evolution of the remnant based on
partial gene loss in C. gattii and complete gene loss in C. neoformans.
C) A model for the evolution of the remnant based on gene
conversion within C. gattii.
(TIFF)
Table S1 Summary of mating assays and fertility. Top
four isolates for fertility from each mating type indicate isolates
that mated with the largest number of opposite mating type
partners.
(XLSX)
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